Mordi Rabinovich is a leading expert in Market Access, NHB processes and pharmacoeconomics. Formerly Head of the Department of Health Technology Policy at Maccabi Healthcare Services (an Israeli sick-fund insuring 2 million people), Associate Director Market Access & Reimbursement at Gilead Israel and Director of Customer Strategy at AstraZeneca Israel. Holds a Ph.D degree from the Department of Health Systems Management at Ben-Gurion University, B.Pharm from the Hebrew University and MBA degree from Tel-Aviv University. Led the field of Health Technology Assessment in Maccabi HMO related to formulary decisions and NHB updates. Represented Maccabi at the National NHB Committee & economic sub-committee, and coordinated the “Health Technology Forum”, a policy setting forum for drugs and medical technologies in the HMO, headed by the CEO. In his roles at the pharmaceutical industry had overall responsibility of NHB and sick-funds strategy, led NHB and sick-funds reimbursement processes. During his work as an independent consultant led reimbursement processes of dozens of pharmaceutical products and medical devices, with high success rates.